Le Lézard
Classified in: Covid-19 virus

Sleep Disorders Treatment Global Market Outlook to 2027: Players Include Jazz Pharmaceuticals, Merck & Co, Pfizer, Sanofi and Vanda Pharmaceuticals - ResearchAndMarkets.com


The "Sleep Disorders Treatment: Global Market Outlook" report has been added to ResearchAndMarkets.com's offering.

The report provides an overview of the global sleep disorders treatment market and analyzes market trends. Using 2021 as the base year, the report provides estimated market data for the forecast period, 2022-2027.

Companies Mentioned

The scope of the report includes pharmaceutical sales and anxiolytic consumption, as well as hypnotics and sedative consumption, non-mental health related disorders, and all other types of medications that aid in improving sleep quality.

Factors such as rising rates of depression and other medical disorders, late-night working schedules, a hectic lifestyle, a lack of quality sleep, and an aging population drive market growth.

As sleep disorders become more common, the demand for sleep problem treatment alternatives will rise. As a result, it is expected that increased mental stress caused by a hectic lifestyle and bad habits will fuel the growth of the market for treating sleep disorders.

Because of the seriousness of the negative effects, patients may be afraid to consume medication, lowering demand and sales. Growing technological development is increasing the market's demand for sleep disorder treatments.

Additionally, medications for the treatment of chronic conditions are used over an extended time and have side effects that are thought to impair a patient's ability to sleep.

Therefore, the market is growing as chronic diseases like cancer become more common. For instance, The National Institute of Cancer (NIC) found that, in 2021, 1,806,590 cancer cases were identified in the U.S. The adverse effects of cancer chemotherapy on the patient's body affect sleep quality.

In this report, the global market for sleep disorders treatment has been segmented based on product type, medication type, and geography. Based on product type, the sleep disorders treatment market has been categorized into antidepressants, benzodiazepines, nonbenzodiazepines, melatonin antagonists, and others.

Based on medication type, the sleep disorders treatment market is categorized into OTC drugs, herbal drugs, and prescription-based drugs. By geography, the market has been segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. The North America region is currently the most dominant market for the sleep disorders treatment market.

Report Includes

Key Topics Covered:

Chapter 1 Market Outlook

Chapter 2 Executive Summary

Chapter 3 Market Overview

3.1 Overview

3.2 Different Types of Sleep Disorders

3.3 Future of Sleep Disorder Treatment

3.4 Market Dynamics

3.4.1 Market Drivers

3.4.2 Market Restraints

3.4.3 Market Challenges

3.5 Macroeconomic Factors of Market for Sleep Disorder Treatments

3.5.1 Impact of Covid-19 on Market for Sleep Disorder Treatments

3.5.2 Impact of Russia-Ukraine War on Market for Sleep Disorder Treatments

Chapter 4 Market Opportunities and Technology Snapshot

Chapter 5 Market Breakdown by Drug/Product Type

Chapter 6 Market Breakdown by Region

6.1 Overview

6.2 North America

6.3 Europe

6.4 Asia-Pacific

6.5 Latin America

6.6 Middle East and Africa

Chapter 7 Company Profiles

Chapter 8 Project Scope and Methodology

For more information about this report visit https://www.researchandmarkets.com/r/q7h10o

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


These press releases may also interest you

at 17:05
Sky Harbour Group Corporation ("SHG" or the "Company"), an aviation infrastructure company building the first nationwide network of Home-Basing campuses for business aircraft, today announced that it will release its First Quarter 2024 financial...

at 17:00
Victoria Gold Corp. ("Victoria" or the "Company") held its Annual General Meeting (the "Meeting") earlier today, May 10, 2024, in Vancouver, British Columbia. Shareholders voted in favour of all items proposed by the board of directors and...

at 17:00
Canada Jetlines Operations Ltd. (Cboe CA:CJET) ("Canada Jetlines" or the "Company"), one of Canada's leading leisure airlines, today reported financial results for the first quarter ended March 31, 2024. All financial figures are...

at 16:16
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class Period") of the important June 11, 2024 lead...

at 16:05
Applied DNA Sciences, Inc. ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced consolidated financial results for its second fiscal quarter ended March 31, 2024. The Company's Form 10-Q can...

at 14:41
Striking new work from the acclaimed visual artist behind the Covid flags on the Mall opened to the public today at Freedom Plaza in Washington, D.C. Suzanne Brennan Firstenberg launched her latest work "alienable right to life," at a moving opening...



News published on and distributed by: